145 related articles for article (PubMed ID: 31292683)
1. Correction to: Population pharmacokinetics of PF‑05280014 (a trastuzumab biosimilar) and reference trastuzumab (Herceptin
Chen X; Li C; Ewesuedo R; Yin D
Cancer Chemother Pharmacol; 2019 Sep; 84(3):667. PubMed ID: 31292683
[TBL] [Abstract][Full Text] [Related]
2. Safety survey on infusion reaction and cardiac dysfunction when switching from reference trastuzumab (HERCEPTIN
Abe T; Sagara A; Okada D; Matsuzaka K
Mol Clin Oncol; 2023 May; 18(5):41. PubMed ID: 37035469
[TBL] [Abstract][Full Text] [Related]
3. PF-05280014: A Trastuzumab Biosimilar.
Paik J
BioDrugs; 2018 Oct; 32(5):515-518. PubMed ID: 30280367
[TBL] [Abstract][Full Text] [Related]
4. PF-05280014 (a trastuzumab biosimilar) plus paclitaxel compared with reference trastuzumab plus paclitaxel for HER2-positive metastatic breast cancer: a randomised, double-blind study.
Pegram MD; Bondarenko I; Zorzetto MMC; Hingmire S; Iwase H; Krivorotko PV; Lee KS; Li RK; Pikiel J; Aggarwal R; Ewesuedo R; Freyman A; Li R; Vana A; Yin D; Zacharchuk C; Tan-Chiu E
Br J Cancer; 2019 Jan; 120(2):172-182. PubMed ID: 30568294
[TBL] [Abstract][Full Text] [Related]
5. Correction to: Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study.
Hattori M; Ishiguro H; Masuda N; Yoshimura A; Ohtani S; Yasojima H; Morita S; Ohno S; Iwata H
Breast Cancer; 2018 Jan; 25(1):126. PubMed ID: 29159517
[TBL] [Abstract][Full Text] [Related]
6. Correction to: Identification of β‑carboline and canthinone alkaloids as anti‑inflammatory agents but with different inhibitory profile on the expression of iNOS and COX‑2 in lipopolysaccharide‑activated RAW 264.7 macrophages.
Liu P; Li H; Luan R; Huang G; Liu Y; Wang M; Chao Q; Wang L; Li D; Fan H; Chen D; Li L; Matsuzaki K; Li W; Koike K; Zhao F
J Nat Med; 2019 Jun; 73(3):679. PubMed ID: 30712126
[TBL] [Abstract][Full Text] [Related]
7. Correction to: Twenty common errors in the diagnosis and treatment of periprosthetic joint infection.
Li C; Renz N; Trampuz A; Ojeda-Thies C
Int Orthop; 2020 Mar; 44(3):603. PubMed ID: 31822947
[TBL] [Abstract][Full Text] [Related]
8. Correction to: Association between IL-35 and coronary arterial lesions in children with Kawasaki disease.
Su Y; Feng S; Luo L; Liu R; Yi Q
Clin Exp Med; 2019 May; 19(2):269. PubMed ID: 30171456
[TBL] [Abstract][Full Text] [Related]
9. Correction to: Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome Correlations.
Schwartzberg B; Lewin J; Abdelatif O; Bernard J; Bu-Ali H; Cawthorn S; Chen-Seetoo M; Feldman S; Govindarajulu S; Jones L; Juette A; Kavia S; Maganini R; Pain S; Shere M; Shriver C; Smith S; Valencia A; Whitacre E; Whitney R
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):998. PubMed ID: 30298314
[TBL] [Abstract][Full Text] [Related]
10. Correction to: Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer.
Peters ML; de Meijer C; Wyndaele D; Noordzij W; Leliveld-Kors AM; van den Bosch J; van den Berg PH; Baka A; Gaultney JG
Appl Health Econ Health Policy; 2018 Feb; 16(1):145. PubMed ID: 29302922
[TBL] [Abstract][Full Text] [Related]
11. Correction to: Clinical epidemiology of infectious disease among patients with chronic kidney disease.
Ishigami J; Matsushita K
Clin Exp Nephrol; 2019 May; 23(5):723. PubMed ID: 30826978
[TBL] [Abstract][Full Text] [Related]
12. Correction to: China: concurring regulation of cross-border genomic data sharing for statist control and individual protection.
Chen Y; Song L
Hum Genet; 2018 Aug; 137(8):617. PubMed ID: 30120574
[TBL] [Abstract][Full Text] [Related]
13. Correction to: Public goods and procreation.
Anomaly J
Monash Bioeth Rev; 2019 Oct; 37(1-2):79. PubMed ID: 31062293
[TBL] [Abstract][Full Text] [Related]
14. Correction to: Three new ent-abietane diterpenoids from the roots of Euphorbia fischeriana and their cytotoxicity in human tumor cell lines.
Li M; He F; Zhou Y; Wang M; Tao P; Tu Q; Lv G; Chen X
Arch Pharm Res; 2020 Sep; 43(9):982. PubMed ID: 32889664
[TBL] [Abstract][Full Text] [Related]
15. Correction to: Systemic vasculitis involving the breast: a case report and literature review.
Ren J; Liu J; Su J; Zhang J; Zhao J
Rheumatol Int; 2019 Aug; 39(8):1457. PubMed ID: 30972542
[TBL] [Abstract][Full Text] [Related]
16. Correction to: Diffuse leptomeningeal glioneuronal tumor in a Chinese adult: a novel case report and review of literature.
Xu H; Chen F; Zhu H; Luo L; Zhang R
Acta Neurol Belg; 2020 Dec; 120(6):1501. PubMed ID: 31970701
[TBL] [Abstract][Full Text] [Related]
17. Correction to: An efficient transgene-free DNA-editing system for Arabidopsis using a fluorescent marker.
Ouyang L; Ma M; Li L
Biotechnol Lett; 2020 Feb; 42(2):319. PubMed ID: 31863217
[TBL] [Abstract][Full Text] [Related]
18. Correction to: The cellular machineries responsible for the division of endosymbiotic organelles.
Yoshida Y
J Plant Res; 2019 Mar; 132(2):297-298. PubMed ID: 30805737
[TBL] [Abstract][Full Text] [Related]
19. Trastuzumab Biosimilars in the Therapy of Breast Cancer - "Real World" Experiences from four Bavarian University Breast Centres.
Hester A; Gaß P; Fasching PA; Krämer AK; Ettl J; Diessner J; Wöckel A; Egger T; Stock K; Redlin J; Andraschko M; Harbeck N; Würstlein R
Geburtshilfe Frauenheilkd; 2020 Sep; 80(9):924-931. PubMed ID: 32905322
[No Abstract] [Full Text] [Related]
20. Correction to: Skin Care Prevention: Psychosocial Predictors of Sunscreen Use in University Students.
Mirzaei-Alavijeh M; Gharibnavaz H; Jalilian F
J Cancer Educ; 2020 Feb; 35(1):193. PubMed ID: 31802422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
